RWM
JAZZ icon

Rialto Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rialto Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4K Buy
18
+2
+13% +$350 ﹤0.01% 688
2025
Q4 		$2.72K Buy
16
+1
+7% +$153 ﹤0.01% 637
2025
Q3 		$1.98K Buy
15
+1
+7% +$120 ﹤0.01% 675
2025
Q2 		$1.49K Buy
+14
New +$1.52K ﹤0.01% 687

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Rialto Wealth Management's JAZZ Position: Q1 2026 in Review

Rialto Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q1 2026, buying an estimated $350 and bringing the position to 18 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Rialto Wealth Management first reported a position in JAZZ in Q2 2025 and has held it in 4 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Rialto Wealth Management held 18 shares of Jazz Pharmaceuticals worth $3.4K as of Q1 2026.
  • Rialto Wealth Management bought 2 Jazz Pharmaceuticals shares in Q1 2026, an estimated $350.
  • Jazz Pharmaceuticals made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #688 holding.
  • Rialto Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.